These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 15812959)
1. The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation. Gold ER; Adams W; Castle D; de Langavant GC; Cloutier LM; Daar AS; Glass A; Smith PJ; Bernier L Public Aff Q; 2004 Oct; 18(4):299-344. PubMed ID: 15812959 [No Abstract] [Full Text] [Related]
2. The gene patenting controversy: a convergence of law, economic interests, and ethics. Kevles DJ; Berkowitz A Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549 [No Abstract] [Full Text] [Related]
3. Biomedical patents and ethics: a Canadian solution. Gold ER McGill Law J; 2000 May; 45(2):413-35. PubMed ID: 12688288 [TBL] [Abstract][Full Text] [Related]
4. Patenting DNA: who defines and protects the public good? Garcia SA Am J Bioeth; 2002; 2(3):25-6. PubMed ID: 12230850 [No Abstract] [Full Text] [Related]
5. Churches say no to gene patenting. Christ Century; 2000 Sep; 117(25):899-900. PubMed ID: 12528735 [No Abstract] [Full Text] [Related]
6. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany. Schrell A; Bauser H; Brunner H Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818 [TBL] [Abstract][Full Text] [Related]
7. Innovations and intellectual property: the case of genomic patenting. Jackson BA J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760 [TBL] [Abstract][Full Text] [Related]
8. Patenting pluripotence: the next battle for stem cell intellectual property. Vrtovec KT; Scott CT Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018 [TBL] [Abstract][Full Text] [Related]
9. International conflicts over patenting human DNA sequences in the United States and the European Union: an argument for compulsory licensing and a fair-use exemption. Gitter DM N Y Univ Law Rev; 2001 Dec; 76(6):1623-91. PubMed ID: 12741387 [TBL] [Abstract][Full Text] [Related]
10. Should genes be patented? The gene patenting controversy: legal, ethical, and policy foundations of an international agreement. Looney B Law Policy Int Bus; 1994; 26(1):231-72. PubMed ID: 11979605 [No Abstract] [Full Text] [Related]
12. Patents on parts of the human body: salient issues under EC and WTO law. Herdegen M J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546 [No Abstract] [Full Text] [Related]
13. Patent first, ask questions later: morality and biotechnology in patent law. Bagley MA William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677 [TBL] [Abstract][Full Text] [Related]
15. Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies. Feeney O; Cockbain J; Morrison M; Diependaele L; Van Assche K; Sterckx S Am J Bioeth; 2018 Dec; 18(12):36-48. PubMed ID: 31159699 [TBL] [Abstract][Full Text] [Related]
16. Why the European Parliament rejected the patenting of human genes. Grace M Gene Ther; 1995 Oct; 2(8):509-11. PubMed ID: 8593600 [No Abstract] [Full Text] [Related]
17. Patenting life: a view from the constitution and beyond. Schneider CA; Cohn F; Bonner C Whittier Law Rev; 2002; 24(2):385-416. PubMed ID: 15085853 [No Abstract] [Full Text] [Related]
18. The morality of biotech patents: differing legal obligations in Europe? Ford R Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738 [No Abstract] [Full Text] [Related]
19. Towards harmonization: the European biotechnology patent directive. Curley D J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122 [TBL] [Abstract][Full Text] [Related]
20. Ethical aspects of patenting human genotypes according to EC Biotechnology Directive. Spranger TM IIC Int Rev Ind Prop Copyr Law; 2000 Jun; 31(4):373-80. PubMed ID: 12956125 [No Abstract] [Full Text] [Related] [Next] [New Search]